---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-036506"
form_type: "8-K"
ticker: "PVLA"
cik: "0001583648"
company_name: "PALVELLA THERAPEUTICS, INC."
filed_at: "2024-12-03T23:59:59+00:00"
generated_at: "2026-05-29T09:51:35.774356+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Pieris supplements proxy for Palvella merger after 9 shareholder demands and 2 lawsuits

## Summary
- Annual meeting results: Kiritsy and Kiener elected directors; Ernst & Young ratified; say-on-pay approved.
- Received 9 demands and 2 lawsuits alleging insufficient merger disclosures; Pieris denies liability but added supplemental info.
- Supplemental disclosures include updated financial analysis tables, Palvella projections probability-adjusted at 65%, and Transaction Committee fees.
- No action required for stockholders who already submitted proxies; Pieris urges reading the full proxy statement.

## SEC filing metadata
- accession: 0001437749-24-036506
- form_type: 8-K
- ticker: PVLA
- cik: 0001583648
- company_name: PALVELLA THERAPEUTICS, INC.
- filed_at: 2024-12-03T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583648/000143774924036506/0001437749-24-036506-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583648/000143774924036506/pirs20241115_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-036506
- JSON: https://secwatch.observer/filing/0001437749-24-036506.json
- Plain text: https://secwatch.observer/filing/0001437749-24-036506.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.